AAAAAA
Results:
1-23
|
Results: 23
Authors:
Van Vaerenbergh, K
Debaisieux, L
De Cabooter, N
Declercq, C
Desmet, K
Fransen, K
Maes, B
Marissens, D
Miller, K
Muyldermans, G
Sprecher, S
Stuyver, L
Vaira, D
Verhofstede, C
Zissis, G
Van Ranst, M
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70
Authors:
Plotkin, SA
Teuwen, DE
Prinzie, A
Desmyter, J
Citation: Sa. Plotkin et al., Postscript relating to new allegations made by Edward Hooper at the Royal Society Discussion Meeting on 11 September 2000, PHI T ROY B, 356(1410), 2001, pp. 825-829
Authors:
Desmyter, J
Teuwen, DE
Citation: J. Desmyter et De. Teuwen, The Jezierski papers: live polio vaccine development in colobus monkey cells but not chimpanzee cells in the Belgian Congo, 1952-1958, PHI T ROY B, 356(1410), 2001, pp. 835-837
Authors:
Van Laethem, K
Witvrouw, M
Pannecouque, C
Van Remoortel, B
Schmit, JC
Esnouf, R
Kleim, JP
Balzarini, J
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype, AIDS, 15(5), 2001, pp. 553-561
Authors:
Van Laethem, K
Schmit, JC
Pelemans, H
Balzarini, J
Witvrouw, M
Perez-Perez, MJ
Camarasa, MJ
Esnouf, RM
Aquaro, S
Cenci, A
Perno, CF
Hermans, P
Sprecher, S
Ruiz, L
Clotet, B
Van Wijngaerden, E
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Authors:
Van Vaerenbergh, K
Van Laethem, K
Van Wijngaerden, E
Schmit, JC
Schneider, F
Ruiz, L
Clotet, B
Verhofstede, C
Van Wanzeele, F
Muyldermans, G
Simons, P
Stuyver, L
Hermans, P
Evans, C
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Authors:
Salemi, M
Desmyter, J
Vandamme, AM
Citation: M. Salemi et al., Tempo and mode of human and simian T-lymphotropic Virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences, MOL BIOL EV, 17(3), 2000, pp. 374-386
Authors:
Van Laethem, K
Witvrouw, M
Balzarini, J
Schmit, JC
Sprecher, S
Hermans, P
Leal, M
Harrer, T
Ruiz, L
Clotet, B
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Authors:
Sasse, A
Liesnard, C
van der Groen, G
Burtonboy, G
Plum, J
Sondag-Thull, D
Sprecher, S
Van Ranst, M
Zissis, G
Desmyter, J
Citation: A. Sasse et al., Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium, AIDS, 14(17), 2000, pp. 2798-2800
Authors:
Witvrouw, M
Pannecouque, C
Desmyter, J
De Clercq, E
Andries, K
Citation: M. Witvrouw et al., In vitro evaluation of the effect of temporary removal of HIV drug pressure, ANTIVIR RES, 46(3), 2000, pp. 215-221
Authors:
Liu, HF
Muyembe-Tamfum, JJ
Dahan, K
Desmyter, J
Goubau, P
Citation: Hf. Liu et al., High prevalence of GB virus C/hepatitis G virus in Kinshasa, Democratic Republic of Congo: A phylogenetic analysis, J MED VIROL, 60(2), 2000, pp. 159-165
Authors:
Van Vaerenbergh, K
Van Laethem, K
Albert, J
Boucher, CAB
Clotet, B
Floridia, M
Gerstoft, J
Hejdeman, B
Nielsen, C
Pannecouque, C
Perrin, L
Pirillo, MF
Ruiz, L
Schmit, JC
Schneider, F
Schoolmeester, A
Schuurman, R
Stellbrink, HJ
Stuyver, L
Van Lunzen, J
Van Remoortel, B
Van Wijngaerden, E
Vella, S
Witvrouw, M
Yerly, S
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Authors:
Desmyter, J
Citation: J. Desmyter, From Polio to AIDS, 1950-2005, ACT CLIN B, 55(4), 2000, pp. 197-198
Authors:
Vandamme, AM
Witvrouw, M
Pannecouque, C
Balzarini, J
Van Laethem, K
Schmit, JC
Desmyter, J
De Clercq, E
Citation: Am. Vandamme et al., Evaluating clinical isolates for their phenotypic and genotypic resistanceagainst anti-HIV drugs, METH MOL M, 24, 2000, pp. 223-258
Authors:
Van Laethem, K
Van Vaerenbergh, K
Schmit, JC
Sprecher, S
Hermans, P
De Vroey, V
Schuurman, R
Harrer, T
Witvrouw, M
Van Wijngaerden, E
Stuyver, L
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Authors:
Van Brussel, M
Salemi, M
Liu, HF
Goubau, P
Desmyter, J
Vandamme, AM
Citation: M. Van Brussel et al., The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs, REV MED VIR, 9(3), 1999, pp. 155-170
Authors:
Cabrera, C
Witvrouw, M
Gutierrez, A
Clotet, B
Kuipers, ME
Swart, PJ
Meijer, DKF
Desmyter, J
De Clercq, E
Este, JA
Citation: C. Cabrera et al., Resistance of the human immunodeficiency virus to the inhibitory action ofnegatively charged albumins on virus binding to CD4, AIDS RES H, 15(17), 1999, pp. 1535-1543
Authors:
Salemi, M
Vandamme, AM
Desmyter, J
Casoli, C
Bertazzoni, U
Citation: M. Salemi et al., The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy, GENE, 234(1), 1999, pp. 11-21
Authors:
Witvrouw, M
Pannecouque, C
Van Laethem, K
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: M. Witvrouw et al., Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV, AIDS, 13(12), 1999, pp. 1477-1483
Authors:
Hoppenbrouwers, K
Kanra, G
Roelants, M
Ceyhan, M
Vandermeulen, C
Yurdakok, K
Silier, T
Dupuy, M
Pehlivan, T
Ozmert, E
Desmyter, J
Citation: K. Hoppenbrouwers et al., Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey, VACCINE, 17(7-8), 1999, pp. 875-886
Authors:
Hoppenbrouwers, K
Roelants, M
Ethevenaux, C
Vandermeulen, C
Knops, J
Desmyter, J
Citation: K. Hoppenbrouwers et al., The effect of reconstitution of an Haemophilus influenzae type b-tetanus toroid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up, VACCINE, 17(20-21), 1999, pp. 2588-2598
Authors:
Van Dooren, S
Gotuzzo, E
Salemi, M
Watts, D
Audenaert, E
Duwe, S
Ellerbrok, H
Grassmann, R
Hagelberg, E
Desmyter, J
Vandamme, AM
Citation: S. Van Dooren et al., Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] in Latin America (vol 79, pg 2695, 1998), J GEN VIROL, 80, 1999, pp. 1087-1087
Authors:
Vandamme, AM
Van Laethem, K
Schmit, JC
Van Wijngaerden, E
Reynders, M
Debyser, Z
Witvrouw, M
Van Ranst, M
De Clercq, E
Desmyter, J
Citation: Am. Vandamme et al., Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood, EUR J CL IN, 29(5), 1999, pp. 445-452
Risultati:
1-23
|